Critically ill lung cancer patients face 73.5% long-term mortality and 51.9% hospital mortality
Data shows lung cancer patients face high long-term mortality rates
This meta-analysis examines mortality outcomes and predictors for critically ill patients with lung cancer. The study finds a 46.4% ICU mort…
Patients with lung cancer in intensive care face high mortality rates, highlighting the need for early and focused goals of care discussions…
Triple therapy improves SGRQ scores in stable COPD but increases pneumonia risk compared to dual bronchodilation
Triple therapy shows some benefits for people with COPD
This systematic review and Bayesian network meta-analysis of inhaled maintenance therapies for stable COPD found that triple therapy provide…
Triple therapy may improve quality of life for people with COPD, but it also carries a higher risk of pneumonia.
iNKT cell activators show promise in preclinical models for stroke-associated pneumonia immunomodulation
New immune treatments show promise for stroke and pneumonia
This systematic review of 38 preclinical studies examines the immunopathology of stroke-associated pneumonia (SAP) and the role of immunomod…
Researchers identify how stroke triggers immune failure and find a promising new way to protect the lungs from pneumonia infections.
Exercise reduces inflammatory markers in 45.6% of meta-analytic associations, but evidence quality is low
Exercise Shows Link to Lower Inflammation in Chronic Diseases
This umbrella review of 61 meta-analyses (318 associations) found that exercise significantly reduced circulating inflammatory markers in 45…
New research shows that regular exercise may lower key markers of inflammation for people living with chronic conditions like heart disease …
FDA Approves Jascayd (bexotegrast) for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
FDA Approves New Pill Jascayd for Progressive Lung Disease
The FDA has approved Jascayd (bexotegrast), a phosphodiesterase 4 (PDE4) inhibitor, for the treatment of idiopathic pulmonary fibrosis (IPF)…
The FDA has approved Jascayd (bexotegrast) to treat idiopathic pulmonary fibrosis and progressive pulmonary fibrosis in adults. This new ora…
COPD and OSA overlap syndrome is associated with greater disease burden than either condition alone
Overlapping lung and sleep conditions lead to worse health outcomes
This narrative review examines the pathophysiological mechanisms and clinical outcomes of COPD-OSA overlap syndrome. The authors conclude th…
People with both chronic lung disease and sleep apnea face a heavier burden of illness than those with only one condition.
Low-dose corticosteroids reduce 90-day mortality in adults with severe community-acquired pneumonia
Low dose steroids may lower death rates in severe lung infections
This meta-analysis of 4,622 patients found that low-dose corticosteroids (≤400 mg hydrocortisone-equivalent daily) significantly reduced sho…
A review of clinical trials suggests that low-dose corticosteroids can reduce 90-day mortality for adults with severe lung infections like p…
Personalised CT feedback fails to boost quit rates overall in lung cancer screening
Personalized images of lung damage do not increase smoking quit rates
In a randomized controlled trial of 1003 individuals attending lung cancer screening, a personalised smoking cessation package with annotate…
Showing patients their own lung scans does not improve overall smoking quit rates, though it may show different results for women.
Ultrasound Assessment of Diaphragm Function for Predicting Weaning Success in AECOPD Patients
Ultrasound helps predict weaning success for patients with COPD
Diaphragmatic ultrasound parameters provide valuable prognostic insights for weaning outcomes in mechanically ventilated patients with acute…
New analysis shows ultrasound scans can help doctors predict if patients with severe lung disease can safely breathe on their own.
EIT-based PEEP titration reduces mortality rate in patients with acute respiratory distress syndrome
New imaging method shows lower death rates for lung distress
This meta-analysis of 12 studies evaluated EIT-based positive end-expiratory pressure (PEEP) titration compared to traditional methods in pa…
A new imaging technique helps doctors manage breathing for patients with severe lung distress, leading to lower mortality rates in clinical …
Probiotic regimens may reduce cough duration and illness length in children with respiratory infections
Probiotics shorten cough and illness in children
This network meta-analysis evaluated various probiotic regimens, including Bifidobacterium and Lactobacillus, for managing symptoms of respi…
Certain probiotics may shorten coughs and illnesses in healthy kids, but not all strains work equally.
FDA Approves Orenitram (treprostinil) for Pulmonary Arterial Hypertension
FDA approves new pill Orenitram to treat pulmonary arterial hypertension
The FDA approved Orenitram (treprostinil) oral tablets for treatment of pulmonary arterial hypertension (PAH) to delay disease progression a…
The FDA has approved Orenitram (treprostinil) oral tablets to treat pulmonary arterial hypertension (PAH), a serious condition of high blood…